Früh, A.; Loebel, F.; Bodnar, B.; Kilian, L.; Misch, M.; Kalinauskaite, G.; Kluge, A.; Eitner, C.; Onken, J.; Rubarth, K.;
et al. High-Dose Stereotactic Re-Irradiation of Recurrent High-Grade Gliomas: Clinical Outcome and Experience with AI-Based Target Volume Simulation. Cancers 2025, 17, 3423.
https://doi.org/10.3390/cancers17213423
AMA Style
Früh A, Loebel F, Bodnar B, Kilian L, Misch M, Kalinauskaite G, Kluge A, Eitner C, Onken J, Rubarth K,
et al. High-Dose Stereotactic Re-Irradiation of Recurrent High-Grade Gliomas: Clinical Outcome and Experience with AI-Based Target Volume Simulation. Cancers. 2025; 17(21):3423.
https://doi.org/10.3390/cancers17213423
Chicago/Turabian Style
Früh, Anton, Franziska Loebel, Bohdan Bodnar, Larissa Kilian, Martin Misch, Goda Kalinauskaite, Anne Kluge, Chiara Eitner, Julia Onken, Kerstin Rubarth,
and et al. 2025. "High-Dose Stereotactic Re-Irradiation of Recurrent High-Grade Gliomas: Clinical Outcome and Experience with AI-Based Target Volume Simulation" Cancers 17, no. 21: 3423.
https://doi.org/10.3390/cancers17213423
APA Style
Früh, A., Loebel, F., Bodnar, B., Kilian, L., Misch, M., Kalinauskaite, G., Kluge, A., Eitner, C., Onken, J., Rubarth, K., Zips, D., Vajkoczy, P., Senger, C., & Acker, G.
(2025). High-Dose Stereotactic Re-Irradiation of Recurrent High-Grade Gliomas: Clinical Outcome and Experience with AI-Based Target Volume Simulation. Cancers, 17(21), 3423.
https://doi.org/10.3390/cancers17213423